Medically reviewed by Mary Choy, PharmD Key Takeaways Cymbalta is approved for children 7 years and older, but Effexor XR is ...
The results of the current investigation are based on the initial 12-week, open-label acute treatment phase of a randomized withdrawal study of duloxetine in the prevention of relapse of MDD. Results ...